Oncimmune Eases Going-Concern Risk With Sale of Two Subsidiaries for GBP13 Mln
Published: May 22, 2023 at 3:52 a.m. ET By Anthony O. Goriainoff Oncimmune Holdings said Monday that it has sold subsidiaries Oncimmune Ltd. and Oncimmune Europe GmbH for 13 million pounds ($16.2 million) in cash to Freenome Holdings, and that this alongside debt repayment has removed the material uncertainty regarding it remaining a going concern. … [Read more…]